These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15488029)

  • 1. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
    Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
    Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
    Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
    Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
    Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
    Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.
    Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
    Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
    Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
    Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
    Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
    Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
    Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas.
    Wolter M; Scharwächter C; Reifenberger J; Koch A; Pietsch T; Reifenberger G
    Acta Neuropathol; 2003 Oct; 106(4):287-90. PubMed ID: 12898158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
    Pang JC; Chang Q; Chung YF; Teo JG; Poon WS; Zhou LF; Kong X; Ng HK
    Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Reifenberger J; Wolter M; Weber RG; Megahed M; Ruzicka T; Lichter P; Reifenberger G
    Cancer Res; 1998 May; 58(9):1798-803. PubMed ID: 9581815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AXIN1 mutations but not deletions in cerebellar medulloblastomas.
    Baeza N; Masuoka J; Kleihues P; Ohgaki H
    Oncogene; 2003 Jan; 22(4):632-6. PubMed ID: 12555076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in SUFU predispose to medulloblastoma.
    Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
    Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
    Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
    Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
    Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
    Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
    Arjona D; Bello MJ; Alonso ME; Aminoso C; Isla A; De Campos JM; Sarasa JL; Gutierrez M; Villalobo A; Rey JA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):384-94. PubMed ID: 16008822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.